TP53 and B-cell chronic lymphocytic leukemia: This is because del17p is often associated with tumours with high chromosomal instability (CIN) and/or with p53 which has become dysfunctional, and because del17p is not always associated with aggressive tumour behaviour; a study of CLL patient outcomes where del17p is observed at diagnosis reported the presence of cases where disease progression was slow [37].